Single arm, open label, signal seeking, phase II trial of the activity of tucatinib plus trastuzumab in patients with tumours harbouring HER2 amplifications or mutations
ACTRN 12620000767909 Brief Summary This is a substudy of the Cancer Molecular…
Read more arrow_forward